Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody with an optimized Fc domain, exhibiting an EC50 value of 39.33 ng/mL. It is utilized in the research of metastatic HER2-positive breast cancer [1].
説明 | Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody with an optimized Fc domain, exhibiting an EC50 value of 39.33 ng/mL. It is utilized in the research of metastatic HER2-positive breast cancer [1]. |
分子量 | N/A |
CAS No. | 1350624-75-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Margetuximab 1350624-75-7 Inhibitor inhibitor inhibit